Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “dimethyl”

36 pharma patents match "dimethyl" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 36
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 36 pharmaceutical patents matching "dimethyl" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

36 results for “dimethyl” · 30,257 patents in full index Clear search

  1. EP 4691463

    VERFAHREN ZUR PRÄVENTION ODER BEHANDLUNG VON HERZVERSAGEN BEI EINEM PATIENTEN MIT (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXAMID

    BAYER AG [DE] · Granted Feb 11, 2026 · Expires Feb 6, 2046

    granted
  2. US 12344596

    Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  3. US 12338249

    Crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N′-methoxyurea

    Takeda Pharmaceutical Company Limited · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  4. US 12151998

    Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  5. US 11602515

    Pharmaceutical compositions comprising dimethyl fumarate

    Almirall, S.A. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  6. US 11427605

    Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  7. US 11291662

    Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  8. US 11148998

    Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  9. US 10537565

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  10. US 10494382

    Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water

    Theravance Biopharma R&D IP, LLC · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  11. US 10351587

    Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  12. US 10011562

    Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted
  13. US 9931334

    Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted
  14. US 9670163

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  15. US 9586925

    1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia

    NOBEL ILAÇ SANAYII VE TICARET A.S. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  16. US 9139530

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted
  17. US 9045425

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  18. US 8933071

    Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders

    Northwestern University · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  19. US 8785476

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  20. US 8754224

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  21. US 8735408

    Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

    LEXICON PHARMACEUTICALS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  22. US 8674108

    Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  23. US 8471029

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  24. US 8410274

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted